[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 22 of about 22
1. Uematsu Y, Fukai J, Tamura M, Owai Y, Obayashi S, Nakai K, Itakura T: Distant metastasis of dermatofibrosarcoma protuberans of the scalp--case report. Neurol Med Chir (Tokyo); 2003 Oct;43(10):493-6
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A 49-year-old man presented with a rare dermatofibrosarcoma protuberans (DFSP) of the scalp associated with local recurrence and distant metastasis to the lung and abdomen.
  • Repeated relapses and metastasis to the lung were recognized despite surgery, chemotherapy, and local radiation.
  • Eventually, the patient died of distant metastasis to the abdomen 17 years after the initial diagnosis.
  • Scalp DFSP is very uncommon but is an aggressive scalp tumor, so initial wide local resection and local radiation therapy after surgery are important to prevent local recurrence and distant metastasis.
  • [MeSH-major] Dermatofibrosarcoma / secondary. Head and Neck Neoplasms / pathology. Scalp / pathology. Skin Neoplasms / pathology
  • [MeSH-minor] Abdominal Neoplasms / secondary. Fatal Outcome. Humans. Lung Neoplasms / secondary. Male. Middle Aged. Neoplasm Invasiveness. Neoplasm Recurrence, Local / pathology

  • Genetic Alliance. consumer health - Dermatofibrosarcoma Protuberans.
  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 14620201.001).
  • [ISSN] 0470-8105
  • [Journal-full-title] Neurologia medico-chirurgica
  • [ISO-abbreviation] Neurol. Med. Chir. (Tokyo)
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


2. McLoughlin JM, Zager JS, Sondak VK, Berk LB: Treatment options for limited or symptomatic metastatic melanoma. Cancer Control; 2008 Jul;15(3):239-47
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Treatment options for limited or symptomatic metastatic melanoma.
  • BACKGROUND: Patients who develop metastatic melanoma often have limited effective treatment options.
  • RESULTS: A thorough preoperative staging includes positron-emission tomography, MRI of the brain, and CT of the chest, abdomen, and pelvis.
  • Surgery and other multimodality treatment options can be used for symptomatic palliation but will not affect survival.
  • Chemotherapy and radiation are often used to control the symptoms of brain and bony metastases but have limited if any impact on survival.
  • Identifying which patients will benefit from treatment requires good clinical judgment and a thorough radiologic evaluation to identify the true extent of disease.
  • [MeSH-major] Melanoma / therapy. Skin Neoplasms / therapy
  • [MeSH-minor] Combined Modality Therapy / methods. Humans. Neoplasm Metastasis. Neoplasm Staging. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Melanoma.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18596676.001).
  • [ISSN] 1073-2748
  • [Journal-full-title] Cancer control : journal of the Moffitt Cancer Center
  • [ISO-abbreviation] Cancer Control
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 90
  •  go-up   go-down


3. Garg PK, Khurana N, Hadke NS: Subcutaneous and breast metastasis from asymptomatic gallbladder carcinoma. Hepatobiliary Pancreat Dis Int; 2009 Apr;8(2):209-11
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Gallbladder carcinoma metastasizing to breast and subcutaneous tissue is not known.
  • The patient was investigated for a primary neoplasm.
  • An ultrasound of the abdomen followed by a contrast-enhanced CT scan showed a growth in gallbladder, infiltrating the liver with multiple hepatic metastases.
  • She was diagnosed as a case of metastatic adenocarcinoma of the gallbladder and palliative combination chemotherapy with gemcitabine and carboplatin was given.
  • But she developed jaundice and deteriorated dramatically in a short span of time.
  • No specific therapy could be started and she was given supportive treatment.
  • She died within three weeks of diagnosis due to hepatic encephalopathy.
  • CONCLUSIONS: This report highlights an unusual metastasis of gallbladder carcinoma to the breast and subcutaneous tissue presenting as multiple lesions, which has never been reported in the English literature.
  • [MeSH-major] Breast Neoplasms / secondary. Skin Neoplasms / secondary

  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19357037.001).
  • [ISSN] 1499-3872
  • [Journal-full-title] Hepatobiliary & pancreatic diseases international : HBPD INT
  • [ISO-abbreviation] HBPD INT
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] China
  •  go-up   go-down


Advertisement
4. Kiyohara T, Kumakiri M, Kobayashi H, Shimizu T, Ohkawara A, Ohnuki M: A case of intravascular large B-cell lymphoma mimicking erythema nodosum: the importance of multiple skin biopsies. J Cutan Pathol; 2000 Sep;27(8):413-8
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A case of intravascular large B-cell lymphoma mimicking erythema nodosum: the importance of multiple skin biopsies.
  • The second biopsy revealed emboli of atypical lymphocytes within many of the dilated and proliferated vessels in the deep dermis and subcutaneous tissue.
  • These findings confirmed the diagnosis of intravascular large B-cell lymphoma.
  • An MRI of the brain and computed tomographic (CT) scans of the chest and abdomen revealed no evidence of malignancy.
  • Before the treatment, the size of the nodules decreased spontaneously by about 50% in one month and significantly in two months.
  • Although combination chemotherapy, which consisted of CHOP, brought her partial remission, she experienced neurological symptoms 6 months after the initial treatment and died of brain metastasis 9 months after the treatment.
  • 1) the first biopsy revealed non-specific findings compatible with erythema nodosum; and 2) before the treatment, the nodules regressed spontaneously.
  • Dermatologists should take multiple skin biopsies for EN lesions with the non-specific histopathological findings not to refute the existence of this disease.
  • [MeSH-major] Erythema Nodosum / diagnosis. Lymphoma, B-Cell / diagnosis. Lymphoma, Large B-Cell, Diffuse / diagnosis. Neoplasm Regression, Spontaneous / pathology. Neoplasms, Vascular Tissue / diagnosis. Skin Neoplasms / diagnosis
  • [MeSH-minor] Biopsy. Diagnosis, Differential. Female. Humans. Middle Aged. Skin / blood supply. Skin / pathology

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 10955689.001).
  • [ISSN] 0303-6987
  • [Journal-full-title] Journal of cutaneous pathology
  • [ISO-abbreviation] J. Cutan. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] DENMARK
  •  go-up   go-down


5. Post IC, van Ingen G, Hendriks TR, Plaisier PW: [A 73-year-old man with a Merkel cell carcinoma]. Ned Tijdschr Geneeskd; 2010;154:A1974
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The diagnosis was made on the basis of characteristic histopathological findings and a surgical excision with wide margins followed.
  • During a CT scan of the thorax and abdomen, 2 suspicious abnormalities were seen in the mesenterial adipose tissue of the left lower abdomen and left perirenal adipose tissue.
  • A tissue sample of the last abnormality taken under CT guidance confirmed this to be a metastasis of the MCC.
  • The patient was irradiated but chose not to have chemotherapy.
  • He died 2 years after the diagnosis.
  • Merkel cell carcinoma is a rare and aggressive malignant skin neoplasm.
  • Treatment is multidisciplinary, but surgery, either alone or in combination with radiotherapy, forms the basis of treating both the localised and regionalized forms of the disease.
  • Chemotherapy may be used in case of disseminated disease and has a reasonable, albeit temporary, effect.
  • [MeSH-major] Carcinoma, Merkel Cell / diagnosis. Neoplasms, Adipose Tissue / diagnosis. Skin Neoplasms / diagnosis
  • [MeSH-minor] Aged. Fatal Outcome. Humans. Male. Neoplasm Metastasis. Prognosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21029484.001).
  • [ISSN] 1876-8784
  • [Journal-full-title] Nederlands tijdschrift voor geneeskunde
  • [ISO-abbreviation] Ned Tijdschr Geneeskd
  • [Language] dut
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


6. Sakuma T, Nomizu T, Miyamoto K, Ogino A, Yamada M, Katagata N, Watanabe F, Yamaguchi Y: Locally advanced and metastatic breast cancer with cartilaginous and/or osseous metaplasia showing excellent response to chemotherapy. Breast Cancer; 2004;11(4):401-8
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Locally advanced and metastatic breast cancer with cartilaginous and/or osseous metaplasia showing excellent response to chemotherapy.
  • We report a case of breast cancer with cartilaginous and/or osseous metaplasia that was StageIV,(T4bN0M1b (PUL)), on the basis of the Japanese General Rules for Clinical and Pathological Recording of Breast Cancer, which responded well to chemotherapy.
  • Chest computed tomography (CT) demonstrated multiple lung metastases.
  • CAF was given to the patient as preoperative chemotherapy.
  • Five cycles of treatment yielded improvement at the primary site and improvement of the metastatic lung lesions, which was judged as a partial response.
  • In November 2002, the patient underwent a right simple mastectomy with whole-layer skin grafting from the abdomen.
  • The final pathological diagnosis was a rare type of breast cancer with cartilaginous and/or osseous metaplasia.
  • Preoperative chemotherapy had caused necrosis in most of the tumor cells, and the efficacy was judged as Grade 2.
  • [MeSH-major] Breast Neoplasms / diagnosis. Lung Neoplasms / diagnosis. Sarcoma / diagnosis
  • [MeSH-minor] Diagnosis, Differential. Female. Humans. Mastectomy. Middle Aged. Neoadjuvant Therapy. Neoplasm Metastasis. Neoplasm Staging. Tomography, X-Ray Computed


7. McClay EF, McClay ME, Monroe L, Baron PL, Cole DJ, O'Brien PH, Metcalf JS, Maize JC: The effect of tamoxifen and cisplatin on the disease-free and overall survival of patients with high risk malignant melanoma. Br J Cancer; 2000 Jul;83(1):16-21
Hazardous Substances Data Bank. DEXAMETHASONE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The adjuvant treatment of high-risk malignant melanoma remains problematic.
  • Previously we reported moderate success in the treatment of metastatic disease using tamoxifen, cisplatin, dacarbazine and carmustine.
  • During the first 2 years of follow-up, patients were evaluated every 2 months with a history, physical exam, laboratory work and computed tomography scans of the chest, abdomen and pelvis every 4 months.
  • No effect of gender or number of positive lymph nodes was noted, however, stage of disease prior treatment was a factor.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Chemotherapy, Adjuvant. Melanoma / drug therapy. Skin Neoplasms / drug therapy
  • [MeSH-minor] Adult. Aged. Antiemetics / therapeutic use. Cisplatin / administration & dosage. Cisplatin / adverse effects. Combined Modality Therapy. Dexamethasone / therapeutic use. Disease-Free Survival. Female. Follow-Up Studies. Granisetron / therapeutic use. Humans. Life Tables. Lymphatic Metastasis. Male. Middle Aged. Nausea / chemically induced. Nausea / prevention & control. Neoplasm Metastasis. Neoplasm Staging. Ondansetron / therapeutic use. Prognosis. Risk. Survival Analysis. Tamoxifen / administration & dosage. Tamoxifen / adverse effects. Treatment Outcome. Vomiting / chemically induced. Vomiting / prevention & control

  • MedlinePlus Health Information. consumer health - Melanoma.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. TAMOXIFEN .
  • Hazardous Substances Data Bank. CIS-DIAMINEDICHLOROPLATINUM .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Natl Cancer Inst. 1989 Dec 20;81(24):1893-904 [2593166.001]
  • [Cites] Cancer. 1989 Apr 1;63(7):1292-5 [2920358.001]
  • [Cites] J Clin Oncol. 1991 May;9(5):736-40 [2016616.001]
  • [Cites] Cancer. 1992 Jan 15;69(2):427-9 [1728371.001]
  • [Cites] Int J Cancer. 1992 Feb 20;50(4):553-6 [1537621.001]
  • [Cites] N Engl J Med. 1992 Aug 20;327(8):516-23 [1635566.001]
  • [Cites] Ann Plast Surg. 1992 Jan;28(1):65-9 [1642409.001]
  • [Cites] Cancer Res. 1992 Dec 15;52(24):6790-6 [1458467.001]
  • [Cites] Cancer Res. 1993 Apr 1;53(7):1571-6 [8453625.001]
  • [Cites] Eur J Cancer. 1993;29A(9):1237-42 [8343260.001]
  • [Cites] Cancer. 1993 Sep 15;72(6):1914-8 [8364868.001]
  • [Cites] Int J Cancer. 1993 Dec 2;55(6):1018-22 [8253520.001]
  • [Cites] Am J Clin Oncol. 1994 Feb;17(1):55-9 [8311008.001]
  • [Cites] Lancet. 1994 Apr 9;343(8902):913-4 [7908370.001]
  • [Cites] Cancer. 1994 Apr 15;73(8):2119-30 [8156517.001]
  • [Cites] Br J Cancer. 1994 Sep;70(3):449-52 [8080729.001]
  • [Cites] J Clin Oncol. 1995 Nov;13(11):2776-83 [7595738.001]
  • [Cites] J Clin Oncol. 1996 Jan;14(1):7-17 [8558223.001]
  • [Cites] Oncology (Williston Park). 1995 Nov;9(11):1149-58; discussion 1163-4, 1167-8 [8703684.001]
  • [Cites] J Clin Oncol. 1996 Jul;14(7):2083-90 [8683240.001]
  • [Cites] J Clin Oncol. 1996 Oct;14(10):2666-73 [8874325.001]
  • [Cites] J Clin Oncol. 1998 Apr;16(4):1425-9 [9552047.001]
  • [Cites] J Clin Oncol. 1991 May;9(5):729-35 [2016615.001]
  • [Cites] J Clin Oncol. 1999 Jun;17(6):1884-90 [10561229.001]
  • [Cites] Cancer Treat Rep. 1984 Nov;68(11):1403-5 [6541973.001]
  • [Cites] Cancer Treat Rep. 1987 May;71(5):465-9 [3567970.001]
  • [CommentIn] Br J Cancer. 2000 Jul;83(1):6-7 [10883660.001]
  • (PMID = 10883662.001).
  • [ISSN] 0007-0920
  • [Journal-full-title] British journal of cancer
  • [ISO-abbreviation] Br. J. Cancer
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / CA52151
  • [Publication-type] Clinical Trial; Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] SCOTLAND
  • [Chemical-registry-number] 0 / Antiemetics; 094ZI81Y45 / Tamoxifen; 4AF302ESOS / Ondansetron; 7S5I7G3JQL / Dexamethasone; Q20Q21Q62J / Cisplatin; WZG3J2MCOL / Granisetron
  • [Other-IDs] NLM/ PMC2374536
  •  go-up   go-down


8. Saint-Cyr I, Vezon G, Boisseau-Garsaud AM, Calès-Quist D, Panelatti G, Ossondo M: [Panniculitis induced by MINE chemotherapy]. Ann Dermatol Venereol; 2001 Jun-Jul;128(6-7):756-8
Hazardous Substances Data Bank. VINBLASTINE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Panniculitis induced by MINE chemotherapy].
  • [Transliterated title] Hypodermite secondaire à une chimiothérapie de type MINE.
  • BACKGROUND: Drug-induced panniculitis are uncommon.
  • We report the second case of panniculitis induced by MINE chemotherapy.
  • Multiple erythematous and painful nodules of panniculitis developed on her chest, abdomen and thighs fifteen days after the beginning of drug administration with a second flare up after second administration of the same drugs.
  • The eruption cleared slowly after treatment withdrawal.
  • DISCUSSION: To our knowledge, our case is the second reported case of panniculitis induced by MINE chemotherapy.
  • Drug-induced panniculitis is uncommon and usually induced by steroid treatment.
  • Few cutaneous adverse effects are reported with MINE chemotherapy: rash, erythema and swelling of extremities.
  • A case of inflammatory swelling of thighs with hemorrhagic panniculitis due to this treatment has been described recently.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / adverse effects. Drug Eruptions / diagnosis. Etoposide / adverse effects. Hodgkin Disease / drug therapy. Ifosfamide / adverse effects. Mitoguazone / adverse effects. Panniculitis / chemically induced. Vinblastine / adverse effects
  • [MeSH-minor] Adult. Biopsy. Female. Humans. Neoplasm Staging. Skin / pathology

  • Genetic Alliance. consumer health - Panniculitis.
  • MedlinePlus Health Information. consumer health - Hodgkin Disease.
  • Hazardous Substances Data Bank. ETOPOSIDE .
  • Hazardous Substances Data Bank. IFOSFAMIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 11460041.001).
  • [ISSN] 0151-9638
  • [Journal-full-title] Annales de dermatologie et de vénéréologie
  • [ISO-abbreviation] Ann Dermatol Venereol
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  • [Chemical-registry-number] 5V9KLZ54CY / Vinblastine; 6PLQ3CP4P3 / Etoposide; OD5Q0L447W / Mitoguazone; UM20QQM95Y / Ifosfamide; MINE regimen
  •  go-up   go-down


9. Zhao J, Han B, Shen T, Zhao Y, Wang T, Liu Y, Fang K, Zhong D, Ling Q: Primary cutaneous diffuse large B-cell lymphoma (leg type) after renal allograft: case report and review of the literature. Int J Hematol; 2009 Jan;89(1):113-7
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary cutaneous diffuse large B-cell lymphoma (leg type) after renal allograft: case report and review of the literature.
  • We report a case of a 58-year-old man who presented with a rapidly growing proliferative lesion on the left lower limb, clinically resembling a soft tissue sarcoma 3 years after renal allograft.
  • There was no evidence of systemic involvement on bone marrow needle aspiration and computed tomography (CT) scans of the chest and abdomen.
  • The lesion turned out to be primary cutaneous diffuse large B-cell lymphoma, leg type (PCLBCL LT), as defined in the recent World Health Organization-European Organization for Research and Treatment of Cancer (WHO-EORTC) classification of cutaneous lymphomas by skin biopsy.
  • Immunosuppression reduction, chemotherapy with CHOP regimen and local radiotherapy induced complete remission of the tumor.
  • [MeSH-minor] Humans. Leg / pathology. Male. Middle Aged. Neoplasm Invasiveness. Remission Induction / methods. Skin Neoplasms / etiology. Skin Neoplasms / pathology

  • Genetic Alliance. consumer health - Large B cell diffuse lymphoma.
  • MedlinePlus Health Information. consumer health - Kidney Transplantation.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Oncol. 2001 Aug 15;19(16):3602-10 [11504742.001]
  • [Cites] Pediatr Transplant. 2005 Oct;9(5):622-6 [16176420.001]
  • [Cites] J Cardiovasc Pharmacol Ther. 2006 Mar;11(1):77-83 [16703222.001]
  • [Cites] Arch Dermatol. 2004 Sep;140(9):1140-6 [15381556.001]
  • [Cites] Blood. 2005 May 15;105(10):3768-85 [15692063.001]
  • [Cites] Clin Transplant. 2005 Oct;19(5):668-73 [16146560.001]
  • [Cites] Br J Dermatol. 2005 Nov;153(5):874-80 [16225594.001]
  • [Cites] Transplant Proc. 2006 Mar;38(2):641-5 [16549195.001]
  • [Cites] Transplant Proc. 2007 May;39(4):1071-3 [17524894.001]
  • [Cites] Clin Transplant. 2005 Jun;19(3):327-34 [15877793.001]
  • [Cites] Am J Transplant. 2006 Nov;6(11):2735-42 [17049061.001]
  • [Cites] Am J Clin Pathol. 2002 Apr;117(4):574-80 [11939732.001]
  • [Cites] Arch Dermatol. 2007 Sep;143(9):1144-50 [17875875.001]
  • [Cites] Transplantation. 2005 Sep 15;80(5):595-9 [16177631.001]
  • [Cites] Transplant Proc. 2006 Oct;38(8):2448-50 [17097963.001]
  • [Cites] Blood. 2002 Feb 1;99(3):800-5 [11806979.001]
  • [Cites] J Cutan Pathol. 2005 Nov;32(10):647-74 [16293178.001]
  • [Cites] Transplantation. 2006 Mar 27;81(6):888-95 [16570013.001]
  • [Cites] Arch Dermatol. 2005 Sep;141(9):1139-45 [16172311.001]
  • [Cites] Eur J Gastroenterol Hepatol. 2006 Oct;18(10):1065-70 [16957512.001]
  • [Cites] Transplantation. 2005 Jul 27;80(2):193-7 [16041263.001]
  • (PMID = 19109733.001).
  • [ISSN] 1865-3774
  • [Journal-full-title] International journal of hematology
  • [ISO-abbreviation] Int. J. Hematol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Japan
  • [Number-of-references] 21
  •  go-up   go-down


10. Martin DR, Danrad R, Herrmann K, Semelka RC, Hussain SM: Magnetic resonance imaging of the gastrointestinal tract. Top Magn Reson Imaging; 2005 Feb;16(1):77-98
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Removal of fat signal for detection of enhancing normal and abnormal structures is critical.
  • Generalized protocol for comprehensive evaluation of the entire abdomen and pelvis can be used for the following bowel indications: type and severity of inflammatory bowel disease (IBD); identifying enteric abscesses and fistulae; preoperative staging of malignant neoplasms, including rectal carcinoma; differentiating postoperative and radiation therapy changes from recurrent carcinoma; follow-up evaluation of metastases response to localized ablative or systemic chemotherapy.
  • Drawbacks of this technique include: artifacts related to extreme sensitivity to field inhomogeneity, including air-soft tissue interfaces at the patient skin surface, and from retained bowel gas; retained bowel gas is dark against dark bowel wall, impairing bowel wall assessment; and True-FISP does not provide sensitivity for edema, which is superior on single-shot echo-train imaging.
  • Small/large bowel indications for MRI include: inflammatory bowel disease, infectious disease including abscess evaluation or for appendicitis, inflammatory conditions including ischemia, and partial obstruction, malnutrition, and neoplasm search.
  • [MeSH-major] Contrast Media. Gastrointestinal Diseases / diagnosis. Gastrointestinal Tract / pathology. Image Enhancement / methods. Image Interpretation, Computer-Assisted / methods. Magnetic Resonance Imaging / methods

  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16314698.001).
  • [ISSN] 0899-3459
  • [Journal-full-title] Topics in magnetic resonance imaging : TMRI
  • [ISO-abbreviation] Top Magn Reson Imaging
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Contrast Media
  • [Number-of-references] 71
  •  go-up   go-down


11. Bakheet SM, Bakheet R, Ezzat A, Tulbah A, Durakovic A, Hussain S: F-18 FDG positron emission tomography in primary breast non-Hodgkin's lymphoma. Clin Nucl Med; 2001 Apr;26(4):299-301
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] F-18 FDG positron emission tomography in primary breast non-Hodgkin's lymphoma.
  • A 50-year-old woman had an irregular, mobile, firm right breast mass that became progressively larger in the past 3 months that measured 18 x 15 cm at the time of examination.
  • She had no nipple discharge or skin changes.
  • A 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) showed a ring-shaped breast uptake consisting of high peripheral glycolytic activity and a cold center most likely representing necrosis or hemorrhage despite the absence of a history of trauma, surgical intervention, chemotherapy, or radiation to the breast.
  • These results were confirmed by computed tomography of the chest, abdomen, and pelvis.
  • [MeSH-major] Breast Neoplasms / radionuclide imaging. Fluorodeoxyglucose F18. Lymphoma, Non-Hodgkin / radionuclide imaging. Radiopharmaceuticals. Tomography, Emission-Computed
  • [MeSH-minor] Female. Humans. Middle Aged. Neoplasm Staging

  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 11290887.001).
  • [ISSN] 0363-9762
  • [Journal-full-title] Clinical nuclear medicine
  • [ISO-abbreviation] Clin Nucl Med
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  •  go-up   go-down


12. Schuppert F, Berger D, Peters H, Schröder S, Schöfl C, Tischler J, Hiller WF, von zur Mühlen A: [A young woman with neurofibromatosis 1 (Recklinghausen disease), abdominal tumor and hypertension]. Dtsch Med Wochenschr; 2000 Nov 17;125(46):1390-4
Hazardous Substances Data Bank. DOXORUBICIN .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Eine junge Patientin mit Neurofibromatose Typ 1 (Morbus Recklinghausen), Unterbauchtumor und Hypertonus.
  • HISTORY AND ADMISSION FINDINGS: A 38-year-old woman, known to have type 1 neurofibromatosis (NF1; von Recklinghausen's disease) and recurrence of a malignant haemangiopericytoma in the lower abdomen developed hypertension.
  • Physical examination revealed tachycardia and paleness of the distal digits, in addition to multiple neurofibromas and café-au-lait spots.
  • TREATMENT AND COURSE: Because of the extensive local changes the recurrent haemangiopericytoma was only partially resected.
  • At the same time a right adrenalectomy was performed without complication.
  • Instead she was given weekly palliative chemotherapy with adriamycin, with little improvement.
  • [MeSH-major] Abdominal Neoplasms / surgery. Hemangiopericytoma / surgery. Hypertension / complications. Neoplasm Recurrence, Local / surgery. Neoplasms, Second Primary / diagnosis. Neurofibromatosis 1 / diagnosis
  • [MeSH-minor] Adrenal Gland Neoplasms / diagnosis. Adult. Antineoplastic Agents / therapeutic use. Doxorubicin / therapeutic use. Exons. Fatal Outcome. Female. Humans. Nerve Tissue Proteins / genetics. Neurofibromin 1. Palliative Care. Pheochromocytoma / diagnosis. Skin Neoplasms / diagnosis. Tachycardia

  • Genetic Alliance. consumer health - Neurofibromatosis.
  • MedlinePlus Health Information. consumer health - High Blood Pressure.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 11129996.001).
  • [ISSN] 0012-0472
  • [Journal-full-title] Deutsche medizinische Wochenschrift (1946)
  • [ISO-abbreviation] Dtsch. Med. Wochenschr.
  • [Language] ger
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Nerve Tissue Proteins; 0 / Neurofibromin 1; 80168379AG / Doxorubicin
  •  go-up   go-down


13. Baslaim MM, Bakheet SM, Bakheet R, Ezzat A, El-Foudeh M, Tulbah A: 18-Fluorodeoxyglucose-positron emission tomography in inflammatory breast cancer. World J Surg; 2003 Oct;27(10):1099-104
MedlinePlus Health Information. consumer health - Breast Diseases.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] 18-Fluorodeoxyglucose-positron emission tomography in inflammatory breast cancer.
  • We evaluated the usefulness of (18)F-fluorodeoxyglucose-positron emission tomography (FDG-PET) scans for diagnosing and staging IBC.
  • Four patients had follow-up PET scans after chemotherapy.
  • Mammography showed diffuse, increased parenchymal density and skin thickening in 85% and parenchymal distortion in 43%.
  • There was no evidence of distant metastasis on computed tomography of the chest or abdomen.
  • Furthermore, there was skin enhancement in 100%, axillary lymph node in 85%, and skeletal metastases in 14% of the patients, confirmed by bone scintigraphy.
  • [MeSH-major] Breast Neoplasms / diagnostic imaging. Carcinoma, Ductal, Breast / diagnostic imaging. Fluorodeoxyglucose F18. Mastitis / diagnostic imaging. Radiopharmaceuticals. Tomography, Emission-Computed
  • [MeSH-minor] Adult. Bone Neoplasms / diagnostic imaging. Bone Neoplasms / secondary. Female. Humans. Lymphatic Metastasis. Middle Aged. Neoplasm Staging. Reproducibility of Results. Retrospective Studies

  • Genetic Alliance. consumer health - Inflammatory breast cancer.
  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Oncol. 2000 Apr;18(8):1676-88 [10764428.001]
  • [Cites] Surg Clin North Am. 1996 Apr;76(2):411-29 [8610272.001]
  • [Cites] J Nucl Med. 1994 May;35(5):872-5 [8176475.001]
  • [Cites] J Clin Oncol. 1995 Jun;13(6):1470-7 [7751894.001]
  • [Cites] J Clin Oncol. 1993 Nov;11(11):2101-11 [8229124.001]
  • [Cites] Semin Nucl Med. 1998 Oct;28(4):290-302 [9800236.001]
  • [Cites] Am Surg. 1995 Feb;61(2):121-4 [7856970.001]
  • [Cites] Eur J Nucl Med. 1999 Jan;26(1):51-6 [9933662.001]
  • [Cites] J Clin Oncol. 2001 Feb 1;19(3):628-33 [11157012.001]
  • [Cites] Eur J Radiol. 1997 Feb;24(2):124-30 [9097054.001]
  • [Cites] J Clin Oncol. 1996 Jun;14 (6):1848-57 [8656253.001]
  • [Cites] J Clin Oncol. 2000 Apr;18(8):1689-95 [10764429.001]
  • (PMID = 12917770.001).
  • [ISSN] 0364-2313
  • [Journal-full-title] World journal of surgery
  • [ISO-abbreviation] World J Surg
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  •  go-up   go-down


14. Ogawa H, Masuda N, Masuda H, Yamamura J, Nakamori S, Tsujinaka T, Yoshitatu S, Nakashotani N, Ueno H, Matsuyama K, Hattori Y, Todaka K, Nishimura A: [Mohs paste for unresectable local lesion of breast cancer]. Gan To Kagaku Ryoho; 2008 Sep;35(9):1531-4
MedlinePlus Health Information. consumer health - Breast Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A 69 year-old woman suffered from an offensive odor and continuous bleeding from a local recurrence in the skin of her abdomen.
  • Mohs paste is in the hope of improving the QOL for the breast cancer patients with local advanced, unresectable skin lesions.
  • [MeSH-major] Breast Neoplasms / drug therapy. Breast Neoplasms / pathology
  • [MeSH-minor] Aged. Female. Humans. Middle Aged. Neoplasm Staging. Ointments / therapeutic use

  • Genetic Alliance. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18799906.001).
  • [ISSN] 0385-0684
  • [Journal-full-title] Gan to kagaku ryoho. Cancer & chemotherapy
  • [ISO-abbreviation] Gan To Kagaku Ryoho
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Ointments
  •  go-up   go-down


15. Chung JJ, Namiki T, Johnson DW: Cervical cancer metastasis to the scalp presenting as alopecia neoplastica. Int J Dermatol; 2007 Feb;46(2):188-9
International Agency for Research on Cancer - Screening Group. diagnostics - Histopathology and cytopathology of the uterine cervix - digital atlas .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This was confirmed when computerized tomography (CT)-guided lymph node biopsy showed squamous cell carcinoma of the para-aortic lymph nodes histologically consistent with the cervical primary.
  • In addition, there was evidence of lumbar spine metastasis by positron emission tomography (PET) and bone scans.
  • She received several courses of chemotherapy with cisplatin and 5-fluorouracil (5FU), as well as radiation therapy.
  • CT of the abdomen identified widespread metastases in the liver, pancreatic head, and lumbar spine.
  • The patient decided against further treatment for her advanced cervical cancer but did accept hydromorphone for pain.
  • [MeSH-major] Alopecia / etiology. Head and Neck Neoplasms / secondary. Neoplasms, Squamous Cell / secondary. Scalp. Skin Neoplasms / secondary. Uterine Cervical Neoplasms / pathology
  • [MeSH-minor] Female. Humans. Middle Aged. Neoplasm Metastasis


16. Wist EA, Sommer HH, Ostenstad B, Risberg T, Bremnes Y, Mjaaland I: Oral capecitabine in anthracycline- and taxane-pretreated advanced/metastatic breast cancer. Acta Oncol; 2004;43(2):186-9
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Twenty-four patients (50%) had metastases to the liver, 18 to bone, 13 to lung, 10 to regional lymph nodes, 8 to pleura, 7 to the thoracic wall, 5 to skin, 3 to the mediastinum, 1 to breast and 1 had metastasis to the abdomen.
  • Median time to progression was 107 days (CI 95% 85 to 129), and median overall survival was 281 days (CI 95% 164 to 398).
  • [MeSH-major] Antimetabolites, Antineoplastic / administration & dosage. Breast Neoplasms / drug therapy. Deoxycytidine / administration & dosage. Deoxycytidine / analogs & derivatives. Prodrugs / administration & dosage
  • [MeSH-minor] Administration, Oral. Adult. Aged. Anthracyclines / therapeutic use. Bridged Compounds / therapeutic use. Capecitabine. Female. Fluorouracil / analogs & derivatives. Humans. Middle Aged. Neoplasm Metastasis. Taxoids / therapeutic use. Treatment Outcome

  • Genetic Alliance. consumer health - Oral cancer.
  • Genetic Alliance. consumer health - Breast Cancer.
  • Genetic Alliance. consumer health - Metastatic cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • Hazardous Substances Data Bank. CAPECITABINE .
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15163168.001).
  • [ISSN] 0284-186X
  • [Journal-full-title] Acta oncologica (Stockholm, Sweden)
  • [ISO-abbreviation] Acta Oncol
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] Norway
  • [Chemical-registry-number] 0 / Anthracyclines; 0 / Antimetabolites, Antineoplastic; 0 / Bridged Compounds; 0 / Prodrugs; 0 / Taxoids; 0W860991D6 / Deoxycytidine; 1605-68-1 / taxane; 6804DJ8Z9U / Capecitabine; U3P01618RT / Fluorouracil
  •  go-up   go-down


17. Amouri A, Chtourou L, Mnif L, Mdhaffar M, Abid M, Ayedi L, Daoud J, Elloumi M, Boudawara T, Tahri N: [MALT lymphoma of the rectum: a case report treated by radiotherapy]. Cancer Radiother; 2009 Jan;13(1):61-4

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Lymphome de MALT du rectum : à propos d'un cas traité par irradiation.
  • The mucosa-associated lymphoid tissue (MALT) lymphoma is a distinct clinical pathologic entity that develops in diverse anatomic locations such as the stomach, salivary gland, thyroid, lung, skin and breast.
  • No extra-intestinal involvement was found on the staging evaluation, which included computed tomography (CT) of the abdomen, chest, pelvis and a bone marrow biopsy.
  • Repeated colonoscopy 4 months after the end of treatment showed that the rectal tumor had not regressed.
  • The patient was considered to be a non-responder to eradication therapy and was indicated for radiotherapy.
  • He underwent a total of 34 Gy.
  • Complete regression was confirmed by colonoscopic and histologic examination at 2 months after the end of treatment.
  • [MeSH-minor] Biopsy. Chronic Disease. Colonoscopy. Female. Gastritis / complications. Gastritis / diagnosis. Gastritis / drug therapy. Gastrointestinal Hemorrhage / etiology. Helicobacter Infections / complications. Helicobacter Infections / diagnosis. Helicobacter Infections / drug therapy. Helicobacter pylori. Humans. Immunohistochemistry. Middle Aged. Neoplasm Staging. Patient Selection. Radiotherapy Dosage. Rare Diseases. Rectal Diseases / etiology. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19101191.001).
  • [ISSN] 1278-3218
  • [Journal-full-title] Cancer radiothérapie : journal de la Société française de radiothérapie oncologique
  • [ISO-abbreviation] Cancer Radiother
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] France
  • [Number-of-references] 27
  •  go-up   go-down


18. Tinger A, Waldron T, Peluso N, Katin MJ, Dosoretz DE, Blitzer PH, Rubenstein JH, Garton GR, Nakfoor BA, Patrice SJ, Chuang L, Orr JW Jr: Effective palliative radiation therapy in advanced and recurrent ovarian carcinoma. Int J Radiat Oncol Biol Phys; 2001 Dec 1;51(5):1256-63
MedlinePlus Health Information. consumer health - Ovarian Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Effective palliative radiation therapy in advanced and recurrent ovarian carcinoma.
  • PURPOSE: To retrospectively review our experience using radiation therapy as a palliative treatment in ovarian carcinoma.
  • METHODS AND MATERIALS: Eighty patients who received radiation therapy for ovarian carcinoma between 1983 and 1998 were reviewed.
  • The indications for radiation therapy, radiation therapy techniques, details, tolerance, and response were recorded.
  • The actuarial survival rates from initial diagnosis and from the completion of radiation therapy were calculated.
  • Zero to 20 cycles of a platinum-based chemotherapy regimen were delivered before irradiation (median = 6 cycles).
  • The reasons for palliative treatment were: pain (n = 22), mass (n = 23), obstruction of ureter, rectum, esophagus, or stomach (n = 12), a positive second-look laparotomy (n = 9), ascites (n = 8), vaginal bleeding (n = 6), rectal bleeding (n = 1), lymphedema (n = 3), skin involvement (n = 1), or brain metastases with symptoms (n = 11).
  • Some patients received treatment for more than one indication.
  • Treatment was directed to the abdomen or pelvis in 64 patients, to the brain in 11, and to other sites in 5.
  • Only 11% suffered progressive disease during therapy that required discontinuation of the treatment.
  • The 1-, 2-, 3-, and 5-year actuarial survival rates from diagnosis were 89%, 73%, 42%, and 33%, respectively.
  • CONCLUSIONS: In this series of radiation therapy for advanced ovarian carcinoma, the response, survival, and tolerance rates compare favorably to those reported for current second- and third-line chemotherapy regimens.
  • Cooperative groups should consider evaluating prospectively the use of radiation therapy before nonplatinum and/or nonpaclitaxel chemotherapy in these patients.
  • [MeSH-major] Neoplasm Recurrence, Local / radiotherapy. Ovarian Neoplasms / radiotherapy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 11728685.001).
  • [ISSN] 0360-3016
  • [Journal-full-title] International journal of radiation oncology, biology, physics
  • [ISO-abbreviation] Int. J. Radiat. Oncol. Biol. Phys.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


19. Ingen-Housz-Oro S, Bagot M: [Cutaneous lymphomas]. Rev Prat; 2009 Nov 20;59(9):1207-15
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Cutaneous lymphomas are lymphoproliferations affecting skin only at the time of diagnosis.
  • There are two major types, B-cell lymphomas and T-cell lymphomas, which prognosis depends of histological subtype and staging evaluation.
  • In cutaneous B-cell lymphomas, there are two indolent subtypes (primary cutaneous marginal zone B-cell lymphoma and primary cutaneous follicle center lymphoma) and one more aggressive type (primary cutaneous diffuse large B-cell lymphoma, leg type).
  • Staging evaluation with CT-scan of chest, abdomen and pelvis, bone marrow examination if necessary and lymph node biopsy if palpable node over 1 or 1.5 cm diameter, is necessary for therapeutic decision.
  • [MeSH-major] Lymphoma. Skin Neoplasms
  • [MeSH-minor] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Humans. Immunohistochemistry. Lymphoma, B-Cell / diagnosis. Lymphoma, B-Cell / drug therapy. Lymphoma, B-Cell / pathology. Lymphoma, B-Cell / radiography. Lymphoma, B-Cell / radiotherapy. Lymphoma, B-Cell / surgery. Lymphoma, T-Cell / diagnosis. Lymphoma, T-Cell / drug therapy. Lymphoma, T-Cell / pathology. Lymphoma, T-Cell / radiography. Lymphoma, T-Cell / radiotherapy. Lymphoma, T-Cell / surgery. Mycosis Fungoides / diagnosis. Mycosis Fungoides / radiography. Neoplasm Staging. Prognosis. Radiography, Abdominal. Radiography, Thoracic. Sezary Syndrome / diagnosis. Sezary Syndrome / pathology. Sezary Syndrome / radiography. Skin / pathology. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Lymphoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19961071.001).
  • [ISSN] 0035-2640
  • [Journal-full-title] La Revue du praticien
  • [ISO-abbreviation] Rev Prat
  • [Language] fre
  • [Publication-type] Comparative Study; English Abstract; Journal Article; Review
  • [Publication-country] France
  • [Number-of-references] 16
  •  go-up   go-down


20. Colovic N, Jurisic V, Terzic T, Atkinson HD, Colovic M: Immunochemotherapy for Bcl-2 and MUM-negative aggressive primary cutaneous B-cell non-Hodgkin's lymphoma. Arch Dermatol Res; 2009 Oct;301(9):689-92
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Bone marrow biopsy and CT chest, abdomen, and pelvis were negative for systemic lymphoma.
  • [MeSH-major] Antibodies, Monoclonal / therapeutic use. Antineoplastic Agents / therapeutic use. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Lymphoma, Large B-Cell, Diffuse / drug therapy. Skin Neoplasms / drug therapy
  • [MeSH-minor] Adult. Antibodies, Monoclonal, Murine-Derived. Antigens, Neoplasm / metabolism. Cyclophosphamide / therapeutic use. Doxorubicin / therapeutic use. Humans. Immunotherapy. Injections, Intravenous. Male. Prednisone / therapeutic use. Proto-Oncogene Proteins c-bcl-2 / metabolism. Rituximab. Treatment Outcome. Vesicular Transport Proteins / metabolism. Vincristine / therapeutic use

  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • Hazardous Substances Data Bank. RITUXIMAB .
  • Hazardous Substances Data Bank. DOXORUBICIN .
  • Hazardous Substances Data Bank. CYCLOPHOSPHAMIDE .
  • Hazardous Substances Data Bank. PREDNISONE .
  • Hazardous Substances Data Bank. VINCRISTINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19495780.001).
  • [ISSN] 1432-069X
  • [Journal-full-title] Archives of dermatological research
  • [ISO-abbreviation] Arch. Dermatol. Res.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Antibodies, Monoclonal; 0 / Antibodies, Monoclonal, Murine-Derived; 0 / Antigens, Neoplasm; 0 / Antineoplastic Agents; 0 / BCL2L15 protein, human; 0 / Proto-Oncogene Proteins c-bcl-2; 0 / TRAPPC1 protein, human; 0 / Vesicular Transport Proteins; 4F4X42SYQ6 / Rituximab; 5J49Q6B70F / Vincristine; 80168379AG / Doxorubicin; 8N3DW7272P / Cyclophosphamide; VB0R961HZT / Prednisone; CHOP protocol
  •  go-up   go-down


21. Borchers H, Jakse G: [Lymphadenectomy for penile cancer. Diagnostic and prognostic significance as well as therapeutic benefit]. Urologe A; 2005 Jun;44(6):657-61

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Lymphadenectomy for penile cancer. Diagnostic and prognostic significance as well as therapeutic benefit].
  • Lymphadenectomy is an essential part of diagnosis and treatment of the squamous cell carcinoma of the penis.
  • The limits of lymphadenectomy are extended to the radical type of dissection when the frozen section indicates cancer.
  • In this situation it is reasonable to perform imaging studies of the pelvis and abdomen for adequate planning of the surgical approach.
  • Neoadjuvant chemotherapy is reasonable for patients with bulky nodes fixed to the skin or fascia because this improves respectability, freedom from local recurrence and increases survival.
  • Adjuvant chemo- and/or radio-therapy are reserved for extended disease or palliative situations.
  • [MeSH-minor] Clinical Trials as Topic. Humans. Lymphatic Metastasis. Male. Neoplasm Staging. Practice Guidelines as Topic. Practice Patterns, Physicians'. Preoperative Care / methods. Prognosis. Risk Factors

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Curr Opin Urol. 2003 Nov;13(6):467-72 [14560140.001]
  • [Cites] J Urol. 1996 Nov;156(5):1637-42 [8863559.001]
  • [Cites] J Urol. 2003 Aug;170(2 Pt 1):359-65 [12853775.001]
  • [Cites] BJU Int. 2005 Mar;95(4):517-21 [15705071.001]
  • [Cites] Int Urol Nephrol. 2002;34(2):245-50 [12775105.001]
  • [Cites] J Urol. 2002 Jul;168(1):76-80 [12050496.001]
  • [Cites] Arch Ital Urol Androl. 1996 Jun;68(3):169-72 [8767505.001]
  • [Cites] BJU Int. 2001 Sep;88(5):473-83 [11589660.001]
  • [Cites] Ann Oncol. 1997 Nov;8(11):1089-98 [9426328.001]
  • [Cites] J Urol. 2002 Jan;167(1):89-92; discussion 92-3 [11743282.001]
  • [Cites] Acta Oncol. 1988;27(6b):823-4 [2466471.001]
  • [Cites] J Urol. 1992 Mar;147(3):630-2 [1538445.001]
  • [Cites] J Urol. 2002 Oct;168(4 Pt 1):1638-9 [12356050.001]
  • [Cites] Urol Int. 1999;62(4):229-33 [10567890.001]
  • [Cites] Urologe A. 2003 Nov;42(11):1466-9 [14624345.001]
  • [Cites] J Urol. 2000 Jan;163(1):100-4 [10604324.001]
  • [Cites] BJU Int. 2000 Oct;86(6):690-3 [11069378.001]
  • [Cites] Cancer. 1977 Feb;39(2):456-66 [837331.001]
  • [Cites] J Urol. 2001 May;165(5):1506-9 [11342906.001]
  • [Cites] BJU Int. 2003 Aug;92(3):248-50 [12887477.001]
  • [Cites] Urologe A. 2001 Jul;40(4):308-12 [11490865.001]
  • [Cites] J Urol. 1994 May;151(5):1244-9 [7512656.001]
  • [Cites] J Urol. 2003 Apr;169(4):1349-52 [12629358.001]
  • [Cites] J Urol. 2001 Apr;165(4):1138-42 [11257655.001]
  • [Cites] Urology. 2001 Jul;58(1):65-8 [11445481.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1997 Jul 1;38(4):713-22 [9240637.001]
  • [Cites] Mod Pathol. 2001 Oct;14(10):963-8 [11598165.001]
  • [Cites] Int Urol Nephrol. 1999;31(4):525-31 [10668948.001]
  • (PMID = 15891865.001).
  • [ISSN] 0340-2592
  • [Journal-full-title] Der Urologe. Ausg. A
  • [ISO-abbreviation] Urologe A
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 21
  •  go-up   go-down


22. Venkatachalapathy S, Crowe J, Gray A: Atypical presentation of varicella zoster in a patient on alemtuzumab. Br J Haematol; 2007 Aug;138(4):406
MedlinePlus Health Information. consumer health - Chickenpox.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Abdomen, Acute / virology. Antibodies, Monoclonal / therapeutic use. Antibodies, Neoplasm / therapeutic use. Antineoplastic Agents / therapeutic use. Chickenpox / diagnosis. Herpesvirus 3, Human. Immunocompromised Host
  • [MeSH-minor] Antibodies, Monoclonal, Humanized. Humans. Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy. Leukemia, Lymphocytic, Chronic, B-Cell / virology. Male. Middle Aged. Skin / virology

  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17659051.001).
  • [ISSN] 0007-1048
  • [Journal-full-title] British journal of haematology
  • [ISO-abbreviation] Br. J. Haematol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antibodies, Monoclonal; 0 / Antibodies, Monoclonal, Humanized; 0 / Antibodies, Neoplasm; 0 / Antineoplastic Agents; 3A189DH42V / alemtuzumab
  •  go-up   go-down






Advertisement